• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中医药治疗新型冠状病毒肺炎主要症状的研究进展

Research Progress on Main Symptoms of Novel Coronavirus Pneumonia Improved by Traditional Chinese Medicine.

作者信息

Luo Chuan-Hong, Ma Le-le, Liu Hui-Min, Liao Wei, Xu Run-Chun, Ci Zhi-Min, Lin Jun-Zhi, Han Li, Zhang Ding-Kun

机构信息

School of Pharmacy, State Key Laboratory of Characteristic Chinese Drug Resources in Southwest China, Chengdu University of Traditional Chinese Medicine, Chengdu, China.

Central Laboratory, Teaching Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China.

出版信息

Front Pharmacol. 2020 Sep 11;11:556885. doi: 10.3389/fphar.2020.556885. eCollection 2020.

DOI:10.3389/fphar.2020.556885
PMID:33013395
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7516165/
Abstract

Novel coronavirus (COVID-19) pneumonia has become a major threat to worldwide public health, having rapidly spread to more than 180 countries and infecting over 1.6 billion people. Fever, cough, and fatigue are the most common initial symptoms of COVID-19, while some patients experience diarrhea rather than fever in the early stage. Many herbal medicine and Chinese patent medicine can significantly improve these symptoms, cure the patients experiencing a mild 22form of the illness, reduce the rate of transition from mild to severe disease, and reduce mortality. Therefore, this paper summarizes the physiopathological mechanisms of fever, cough, fatigue and diarrhea, and introduces Chinese herbal medicines (Ephedrae Herba, Gypsum Fibrosum, Glycyrrhizae Radix et Rhizoma, Asteris Radix et Rhizoma, Ginseng Radix et Rhizoma, Codonopsis Radix, Atractylodis Rhizoma, ) and Chinese patent medicines (Shuang-huang-lian, Ma-xing-gan-shi-tang, ) with their corresponding therapeutic effects. Emphasis was placed on their material basis, mechanism of action, and clinical research. Most of these medicines possess the pharmacological activities of anti-inflammatory, antioxidant, antiviral, and immunity-enhancement, and may be promising medicines for the treatment or adjuvant treatment of COVID-19 patients.

摘要

新型冠状病毒(COVID-19)肺炎已成为全球公共卫生的重大威胁,迅速传播至180多个国家,感染人数超过16亿。发热、咳嗽和乏力是COVID-19最常见的初始症状,而一些患者在疾病早期会出现腹泻而非发热症状。许多草药和中成药能够显著改善这些症状,治愈轻症患者,降低轻症转重症的比例,并降低死亡率。因此,本文总结了发热、咳嗽、乏力和腹泻的生理病理机制,并介绍了具有相应治疗作用的草药(麻黄、石膏、甘草、紫菀、人参、党参、白术)和中成药(双黄连、麻杏甘石汤)。重点阐述了它们的物质基础、作用机制及临床研究。这些药物大多具有抗炎、抗氧化、抗病毒和增强免疫力的药理活性,可能是治疗或辅助治疗COVID-19患者的有前景的药物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/054b/7516165/dcc2f81cc680/fphar-11-556885-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/054b/7516165/43608f201abe/fphar-11-556885-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/054b/7516165/2515200070bf/fphar-11-556885-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/054b/7516165/dcc2f81cc680/fphar-11-556885-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/054b/7516165/43608f201abe/fphar-11-556885-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/054b/7516165/2515200070bf/fphar-11-556885-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/054b/7516165/dcc2f81cc680/fphar-11-556885-g003.jpg

相似文献

1
Research Progress on Main Symptoms of Novel Coronavirus Pneumonia Improved by Traditional Chinese Medicine.中医药治疗新型冠状病毒肺炎主要症状的研究进展
Front Pharmacol. 2020 Sep 11;11:556885. doi: 10.3389/fphar.2020.556885. eCollection 2020.
2
[Analysis of medication regularity and pharmacodynamic characteristics of traditional Chinese medicine treatment in 444 severe cases of COVID-19].444例新冠肺炎重症病例中医治疗用药规律及药效学特征分析
Zhongguo Zhong Yao Za Zhi. 2020 Jul;45(13):3007-3012. doi: 10.19540/j.cnki.cjcmm.20200427.501.
3
[Medication law and mechanism of traditional Chinese medicine in prevention and treatment of epidemic diseases: based on traditional Chinese medicine theory of cold pestilence].[中药防治疫病的用药规律及作用机制:基于中医寒疫理论]
Zhongguo Zhong Yao Za Zhi. 2022 Sep;47(17):4765-4777. doi: 10.19540/j.cnki.cjcmm.20220528.501.
4
[Study on medication regularity of traditional Chinese medicine in treatment of COVID-19 based on data mining].基于数据挖掘的中医治疗新型冠状病毒肺炎用药规律研究
Zhongguo Zhong Yao Za Zhi. 2020 Mar;45(6):1248-1252. doi: 10.19540/j.cnki.cjcmm.20200220.502.
5
Clinical Studies on the Treatment of Novel Coronavirus Pneumonia With Traditional Chinese Medicine-A Literature Analysis.中医药治疗新型冠状病毒肺炎的临床研究——文献分析
Front Pharmacol. 2020 Sep 10;11:560448. doi: 10.3389/fphar.2020.560448. eCollection 2020.
6
Efficacy of Traditional Chinese Medicine, Maxingshigan-Weijing in the management of COVID-19 patients with severe acute respiratory syndrome: A structured summary of a study protocol for a randomized controlled trial.中药麻杏石甘-苇茎汤治疗新型冠状病毒肺炎重型急性呼吸综合征患者的疗效:一项随机对照试验研究方案的结构化总结
Trials. 2020 Dec 23;21(1):1029. doi: 10.1186/s13063-020-04970-3.
7
[Analysis of traditional Chinese medicine from patent information sharing platform of coronavirus disease 2019 (COVID-19)].[基于2019冠状病毒病(COVID-19)专利信息共享平台的中医药分析]
Zhongguo Zhong Yao Za Zhi. 2020 Jul;45(13):3001-3006. doi: 10.19540/j.cnki.cjcmm.20200330.501.
8
[Study on screening potential traditional Chinese medicines against 2019-nCoV based on Mpro and PLP].基于Mpro和PLP筛选抗2019新型冠状病毒潜在中药的研究
Zhongguo Zhong Yao Za Zhi. 2020 Mar;45(6):1219-1224. doi: 10.19540/j.cnki.cjcmm.20200216.401.
9
Medication Rule Analysis of the Diagnosis and Treatment Programs of Chinese Medicine for the Prevention and Treatment of COVID-19 in China.中医药防治新冠肺炎诊疗方案用药规律分析。
Chin J Integr Med. 2022 Sep;28(9):779-784. doi: 10.1007/s11655-021-2880-1. Epub 2022 Jan 13.
10
[Medication rules of Chinese herbal compound prescriptions for treating angina in national patent database based on multiple data mining].基于多数据挖掘的国家专利数据库中治疗心绞痛的中药复方制剂用药规律研究
Zhongguo Zhong Yao Za Zhi. 2023 Oct;48(20):5659-5667. doi: 10.19540/j.cnki.cjcmm.20230626.501.

引用本文的文献

1
Beneficial Bacterial Modulation by Gypsum Fibrosum and Terra Flava Usta in Gut Microbiota.石膏与伏龙肝对肠道微生物群的有益细菌调节作用
Chin J Integr Med. 2025 Apr 15. doi: 10.1007/s11655-025-4129-x.
2
Exploring the therapeutic mechanism of Yuebi decoction on nephrotic syndrome based on network pharmacology and experimental study.基于网络药理学和实验研究探索越婢汤治疗肾病综合征的作用机制。
Aging (Albany NY). 2024 Sep 20;16(18):12623-12650. doi: 10.18632/aging.206116.
3
Antiviral effect of cannabidiol on K18-hACE2 transgenic mice infected with SARS-CoV-2.

本文引用的文献

1
Farfarae Flos: A review of botany, traditional uses, phytochemistry, pharmacology, and toxicology.款冬花:植物学、传统用途、植物化学、药理学和毒理学的综述。
J Ethnopharmacol. 2020 Oct 5;260:113038. doi: 10.1016/j.jep.2020.113038. Epub 2020 Jun 8.
2
Investigation on ultrasound assisted extraction of saikosaponins from .关于超声辅助从……中提取柴胡皂苷的研究 。(原英文文本不完整,此处补充“柴胡”使句子完整以便理解)
Sep Purif Technol. 2007 Jul 1;55(3):307-312. doi: 10.1016/j.seppur.2006.12.002. Epub 2006 Dec 15.
3
The progress of 2019 novel coronavirus event in China.
大麻二酚对感染 SARS-CoV-2 的 K18-hACE2 转基因小鼠的抗病毒作用。
J Cell Mol Med. 2024 Sep;28(17):e70030. doi: 10.1111/jcmm.70030.
4
The Role of Traditional Chinese Medicine and Chinese Pharmacopoeia in the Evaluation and Treatment of COVID-19.中医药和《中国药典》在评估和治疗 COVID-19 中的作用。
Curr Pharm Des. 2024;30(14):1060-1074. doi: 10.2174/0113816128217263240220060252.
5
Medicinal plant sources and traditional healthcare practices of forest-dependent communities in and around Chunati Wildlife Sanctuary in southeastern Bangladesh.孟加拉国东南部Chunati野生动物保护区及其周边地区依赖森林的社区的药用植物来源和传统医疗实践。
Environ Sustain (Singap). 2022;5(2):207-241. doi: 10.1007/s42398-022-00230-z. Epub 2022 Jun 7.
6
The role of NLRP3 inflammasome in hepatocellular carcinoma.NLRP3炎性小体在肝细胞癌中的作用。
Front Pharmacol. 2023 Apr 20;14:1150325. doi: 10.3389/fphar.2023.1150325. eCollection 2023.
7
Socio-administrative conservation and collection practices of the sacred Thal Kedar forest, Uttarakhand, India.印度北阿坎德邦神圣的塔尔凯达森林的社会行政保护与收集实践
Heliyon. 2023 Mar 21;9(4):e14619. doi: 10.1016/j.heliyon.2023.e14619. eCollection 2023 Apr.
8
Simultaneous determination of multiple components in rat plasma by UHPLC-sMRM for pharmacokinetic studies after oral administration of Qingjin Yiqi Granules.超高效液相色谱-小质谱多反应监测法同时测定大鼠血浆中多种成分用于清气益气颗粒口服给药后的药代动力学研究
Front Pharmacol. 2023 Apr 13;14:1155973. doi: 10.3389/fphar.2023.1155973. eCollection 2023.
9
Liquiritin exhibits anti-acute lung injury activities through suppressing the JNK/Nur77/c-Jun pathway.甘草苷通过抑制JNK/Nur77/c-Jun信号通路发挥抗急性肺损伤作用。
Chin Med. 2023 Apr 3;18(1):35. doi: 10.1186/s13020-023-00739-3.
10
Therapeutic effects of herbal-medicine combined therapy for COVID-19: A systematic review and meta-analysis of randomized controlled trials.中药联合疗法治疗新型冠状病毒肺炎的疗效:一项随机对照试验的系统评价与Meta分析
Front Pharmacol. 2022 Sep 1;13:950012. doi: 10.3389/fphar.2022.950012. eCollection 2022.
2019新型冠状病毒事件在中国的进展。
J Med Virol. 2020 May;92(5):468-472. doi: 10.1002/jmv.25705. Epub 2020 Feb 26.
4
Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury.临床证据不支持使用皮质类固醇治疗2019新型冠状病毒肺炎肺损伤。
Lancet. 2020 Feb 15;395(10223):473-475. doi: 10.1016/S0140-6736(20)30317-2. Epub 2020 Feb 7.
5
Discovering the Major Antitussive, Expectorant, and Anti-Inflammatory Bioactive Constituents in L. Based on the Spectrum-Effect Relationship Combined with Chemometrics.基于谱效关系结合化学计量学研究 L. 的主要镇咳、祛痰和抗炎生物活性成分
Molecules. 2020 Jan 31;25(3):620. doi: 10.3390/molecules25030620.
6
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.中国武汉 99 例 2019 年新型冠状病毒肺炎患者的流行病学和临床特征:描述性研究。
Lancet. 2020 Feb 15;395(10223):507-513. doi: 10.1016/S0140-6736(20)30211-7. Epub 2020 Jan 30.
7
Patchouli alcohol attenuates 5-fluorouracil-induced intestinal mucositis via TLR2/MyD88/NF-kB pathway and regulation of microbiota.香豆素醇通过 TLR2/MyD88/NF-kB 通路和调节微生物群来减轻 5-氟尿嘧啶诱导的肠道黏膜炎。
Biomed Pharmacother. 2020 Apr;124:109883. doi: 10.1016/j.biopha.2020.109883. Epub 2020 Jan 28.
8
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.中国武汉地区 2019 年新型冠状病毒感染患者的临床特征。
Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.
9
Deep-Fried Atractylodis Rhizoma Protects against Spleen Deficiency-Induced Diarrhea through Regulating Intestinal Inflammatory Response and Gut Microbiota.炒白术通过调节肠道炎症反应和肠道微生物群防治脾虚型腹泻。
Int J Mol Sci. 2019 Dec 23;21(1):124. doi: 10.3390/ijms21010124.
10
Antipyretic, Antinociceptive, and Anti-Inflammatory Activities from Leaf Extract in Experimental Wister Rats.实验性Wistar大鼠叶提取物的解热、镇痛和抗炎活性
Medicines (Basel). 2019 Sep 20;6(4):96. doi: 10.3390/medicines6040096.